Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline vs Prednisone in Graves' Orbitopathy
NCT01809444Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Nov 2012
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of doxycycline in Graves Orbitopathy (GO) (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Overall treatment response at 24 weeks. Status: unknown.
02
Drugs
doxycycline
03
Conditions
Graves Orbitopathy (GO)
Beyond the preview
Go deeper on NCT01809444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01809444.